广东聚石化学股份有限公司 广东聚石化学股份有限公司 2024 年度独立董事述职报告 2024 年度独立董事述职报告 本人陈桂林作为广东聚石化学股份有限公司（以下简称"公司"）独立董事， 在 2024 年度（以下简称"报告期"）严格按照《中华人民共和国公司法》《上 市公司独立董事管理办法》《上市公司治理准则》等法律法规、规范性文件以及 《广东聚石化学股份有限公司章程》（以下简称《公司章程》）、《广东聚石化 学股份有限公司独立董事工作制度》（以下简称《独立董事工作制度》）、《广 东聚石化学股份有限公司独立董事专门会议工作细则》《广东聚石化学股份有限 公司董事会审计委员会工作细则》（以下简称《审计委员会工作细则》）、《广 东聚石化学股份有限公司董事会薪酬与考核委员会工作细则》（以下简称《薪酬 与考核委员会工作细则》）的规定和要求，认真、勤勉、独立地履行职责，积极 出席相关会议，认真审议董事会各项议案，充分发挥了独立董事及各专门委员会 委员的作用，切实维护了公司和全体股东的利益。现将本人报告期内履行独立董 事职责情况汇报如下： 一、独立董事的基本情况 （一）现任独立董事个人情况 本人陈桂林，1961 年出生，中国国籍 ...

广东聚石化学股份有限公司 2024 年度独立董事述职报告 广东聚石化学股份有限公司 2024 年度独立董事述职报告 本人孟跃中作为广东聚石化学股份有限公司（以下简称"公司"）独立董事， 在 2024 年度（以下简称"报告期"）严格按照《中华人民共和国公司法》《上 市公司独立董事管理办法》《上市公司治理准则》等法律法规、规范性文件以及 《广东聚石化学股份有限公司章程》（以下简称《公司章程》）、《广东聚石化 学股份有限公司独立董事工作制度》（以下简称《独立董事工作制度》）、《广 东聚石化学股份有限公司独立董事专门会议工作细则》《广东聚石化学股份有限 公司董事会提名委员会工作细则》（以下简称《提名委员会工作细则》）、《广 东聚石化学股份有限公司董事会薪酬与考核委员会工作细则》（以下简称《薪酬 与考核委员会工作细则》）、《广东聚石化学股份有限公司董事会审计委员会工 作细则》（以下简称《审计委员会工作细则》）的规定和要求，认真、勤勉、独 立地履行职责，积极出席相关会议，认真审议董事会各项议案，充分发挥了独立 董事及各专门委员会委员的作用，切实维护了公司和全体股东的利益。现将本人 报告期内履行独立董事职责情况汇报如下： ...

广东聚石化学股份有限公司 2024 年度独立董事述职报告 广东聚石化学股份有限公司 2024 年度独立董事述职报告 本人曾幸荣作为广东聚石化学股份有限公司（以下简称"公司"）独立董事， 在 2024 年度（以下简称"报告期"）严格按照《中华人民共和国公司法》《上 市公司独立董事管理办法》《上市公司治理准则》等法律法规、规范性文件以及 《广东聚石化学股份有限公司章程》（以下简称《公司章程》）、《广东聚石化 学股份有限公司独立董事工作制度》（以下简称《独立董事工作制度》）、《广 东聚石化学股份有限公司董事会提名委员会工作细则》（以下简称《提名委员会 工作细则》）、《广东聚石化学股份有限公司董事会战略委员会工作细则》（以 下简称《战略委员会工作细则》）的规定和要求，认真、勤勉、独立地履行职责， 积极出席相关会议，认真审议董事会各项议案，充分发挥了独立董事及各专门委 员会委员的作用，切实维护了公司和全体股东的利益。现将本人报告期内履行独 立董事职责情况汇报如下： 一、独立董事的基本情况 （一）现任独立董事个人情况 本人曾幸荣，1962 年生，中国国籍，无境外永久居留权，1989 年 12 月毕业 于华南理工大学高分子 ...

Financial Performance - The company's revenue for Q1 2025 was CNY 1,108,648,026.80, a decrease of 7.36% compared to CNY 1,196,736,315.94 in the same period last year[4] - Net profit attributable to shareholders was CNY 8,366,124.00, a significant recovery from a loss of CNY 9,677,859.37 in the previous year[4] - Total operating revenue for Q1 2025 was CNY 1,108,648,026.80, a decrease of 7.35% from CNY 1,196,736,315.94 in Q1 2024[19] - Total operating costs for Q1 2025 were CNY 1,104,294,334.67, down 8.63% from CNY 1,208,678,651.15 in Q1 2024[19] - Net profit for Q1 2025 was CNY 13,578,897.23, compared to a net loss of CNY 4,270,418.73 in Q1 2024[19] - The total comprehensive income for Q1 2025 was CNY 13,386,160.40, compared to a loss of CNY 3,446,430.93 in Q1 2024[20] - Basic earnings per share for Q1 2025 was CNY 0.07, compared to a loss per share of CNY 0.08 in Q1 2024[20] Cash Flow - The net cash flow from operating activities decreased by 37.27% to CNY 38,139,762.51 from CNY 60,795,880.19[4] - Cash flow from operating activities for Q1 2025 was CNY 38,139,762.51, a decrease of 37.36% from CNY 60,795,880.19 in Q1 2024[22] - Cash flow from investing activities for Q1 2025 was negative CNY 81,515,216.98, an improvement from negative CNY 93,448,226.82 in Q1 2024[23] - Cash flow from financing activities for Q1 2025 was CNY 88,967,979.62, significantly higher than CNY 23,216,619.24 in Q1 2024[23] Assets and Liabilities - Total assets at the end of the reporting period were CNY 4,971,333,535.55, down 2.70% from CNY 5,109,031,810.26 at the end of the previous year[5] - The company's current assets totaled RMB 2,210,409,410.49, down from RMB 2,378,234,259.36, indicating a decrease of about 7.1%[14] - Total liabilities decreased to RMB 3,468,938,154.21 from RMB 3,619,763,326.04, reflecting a reduction of about 4.2%[16] - The company's equity attributable to shareholders increased to RMB 1,312,467,812.32 from RMB 1,304,359,416.83, a growth of approximately 0.9%[16] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 4,358[10] - The largest shareholder, Guangzhou Shipan Stone Investment Management Co., Ltd., holds 39.43% of the shares[11] Operational Strategy - The company plans to continue optimizing its operations by closing unprofitable businesses and expanding successful projects, which contributed to the turnaround in profitability[9] - The company has not reported any significant new strategies or product developments during the conference call[13] Research and Development - R&D investment totaled CNY 28,789,465.04, representing 2.60% of revenue, up from 2.41% in the previous year[5] Other Financial Metrics - The company reported a weighted average return on equity of 0.64%, improving from -0.62% in the same period last year[5] - Non-recurring gains and losses amounted to CNY 1,850,505.97 after tax, with significant contributions from asset disposals and government subsidies[8] Inventory and Receivables - Cash and cash equivalents increased to RMB 224,192,184.34 from RMB 151,821,658.90, representing a growth of approximately 47.4%[14] - Accounts receivable rose slightly to RMB 906,868,237.38 from RMB 901,333,565.12, showing an increase of about 0.6%[14] - Inventory decreased to RMB 651,053,301.56 from RMB 754,126,185.54, a decline of approximately 13.7%[14] Borrowings - Long-term borrowings increased to RMB 986,863,014.65 from RMB 812,276,212.05, indicating a rise of about 21.5%[16] - The company reported a decrease in short-term borrowings to RMB 748,479,844.70 from RMB 798,103,379.25, a decline of approximately 6.2%[16]

Financial Performance - The company's operating revenue for 2024 reached ¥4,080,206,398.29, an increase of 10.72% compared to ¥3,685,171,155.3 in 2023[22]. - The net profit attributable to shareholders decreased by 926.31% to -¥236,146,837.06 from ¥28,578,460.37 in the previous year[24]. - The net cash flow from operating activities increased by 64.08% to ¥403,926,506.56, up from ¥246,169,798.09 in 2023[22]. - The total assets rose to ¥5,109,031,810.26, a 4.39% increase from ¥4,894,402,986.9 in 2023[22]. - Basic earnings per share fell to -¥1.95 from ¥0.24 in 2023, a decrease of 912.5%[23]. - The company reported a research and development expense ratio of 3.40% of operating revenue, slightly down from 3.49% in 2023[23]. - The company recorded a net profit attributable to shareholders of -¥226,756,499.25 in the fourth quarter of 2024[26]. - The company achieved operating revenue of CNY 4,080.21 million, a year-on-year increase of 10.72%, with main business revenue of CNY 4,047.01 million, up 10.38% year-on-year[33]. - The net profit attributable to shareholders was CNY -236.15 million, a significant decline of 926.31% year-on-year, while the net profit excluding non-recurring gains and losses was CNY -206.08 million[33]. Risk Management - The company is facing various operational risks, which are detailed in the management discussion and analysis section[4]. - The company has a comprehensive risk statement regarding forward-looking statements, advising investors to be cautious[7]. - The company has not reported any non-operational fund occupation by controlling shareholders or related parties[8]. - The company has not experienced any violations of decision-making procedures regarding external guarantees[8]. - The company has not reported any instances where more than half of the directors could not guarantee the accuracy of the annual report[9]. - The company faces risks related to significant profit declines and potential core technology infringement, which could impact its competitive advantage[80]. Governance and Compliance - The company has confirmed that all board members attended the board meeting, ensuring governance compliance[5]. - The company has established a comprehensive quality management system, adhering to ISO9001:2015 and IATF16949:2016 standards, ensuring product quality across all processes[75]. - The company maintains independence from its controlling shareholder, ensuring no interference in decision-making or operations[152]. - Investor relations are prioritized, with multiple channels for communication and feedback from stakeholders[152]. - The company adheres to strict information disclosure practices, ensuring transparency and equal access to information for all shareholders[153]. - The company held multiple shareholder meetings in 2024, with all proposed resolutions passing without any objections[154]. - The company held a total of 6 board meetings during the year, with 5 conducted in a combined format of on-site and communication[175]. - The supervisory board also held 6 meetings, actively monitoring the management of raised funds and the execution of board resolutions[151]. Research and Development - The company is focusing on expanding its overseas market while enhancing R&D investment to drive high-quality development[33]. - The company has established strategic partnerships with numerous well-known domestic and international enterprises to enhance competitiveness and risk resistance[40]. - The company added 27 authorized invention patents and 23 utility model patents in the reporting period, reflecting its commitment to innovation[38]. - The company is actively involved in the development of new materials, including LCD photoresists and biodegradable materials, through collaborations with various research institutions and universities[41]. - The company’s product "Flame Retardant Polypropylene" was awarded the title of "National Manufacturing Single Champion Product"[38]. - R&D expenses amounted to 138.83 million yuan, an increase of 7.89% year-over-year, representing 3.40% of total revenue[37]. - The company has filed 86 new intellectual property applications during the reporting period, including 70 invention patents, and received 50 new authorizations, with a total of 433 authorized intellectual property projects to date[61]. - The company is focusing on the development of new materials such as LCD photoresists and biodegradable materials, aiming to strengthen its market position[72]. Market Expansion and Strategy - The company is in the process of expanding its market presence and developing new products, although specific details are not provided in the available content[3]. - The company is focusing on sustainable development, responding to increasing market demand for environmentally friendly and recyclable modified plastics[53]. - The company is actively pursuing industrialization of its new products and technologies, with ongoing application validation for its flame retardant products[68]. - The company is expanding its market presence by integrating industry-related R&D platforms and promoting collaborative development across the industry chain[123]. - The company is considering strategic acquisitions to enhance its product portfolio and market presence[162]. - The company plans to expand the production of optical display materials, particularly increasing the output of light guide plates[147]. - The company is expanding its upstream and downstream operations through research成果转化 and acquisitions, aiming to enhance supply chain control and product performance[74]. Employee and Management - The company has established a training program that includes systematic onboarding and ongoing training for employees, focusing on skill development and management training[184]. - The company has a total of 2,172 employees, with 500 in the parent company and 1,672 in major subsidiaries[182]. - The total compensation for R&D personnel increased to 5,449.57 million RMB, with an average salary of 15.98 million RMB[71]. - The company continues to focus on employee motivation through equity incentives to enhance performance and retention[192]. - The average age of key personnel in core technology roles is 45 years, indicating a mature workforce with extensive experience[161]. Production and Operations - The company is currently in the construction or expansion phase for several new businesses, impacting overall profitability and increasing costs[24]. - The company achieved a production capacity of 160,000 tons of isooctane annually, enhancing product competitiveness for use in national VI gasoline blending components[58]. - The company has a production capacity of 81,000 tons for modified plastic particles with a utilization rate of 84.69%[134]. - The company is currently constructing a 10,000-ton capacity for phosphorus pentoxide, with an investment of 2,344.76 million RMB expected to be completed by August 2025[134]. - The company has improved production efficiency by over 30% through a one-step method for synthesizing triazine organic compounds, replacing the traditional multi-step process[55]. Financial Management - The company's cash flow from financing activities decreased by 92.76% year-on-year to 23.40 million RMB, mainly due to increased repayments[112]. - The company's cash and cash equivalents at the end of the period were 151.82 million RMB, down 27.81% from the previous period[114]. - The accounts receivable decreased by 15.62% year-on-year to 2,424.89 million RMB, indicating improved collection efficiency[114]. - The company reported a significant reduction in production costs by 8% due to improved supply chain management[167]. - The company has a total of 1,092,294,487.92 RMB in restricted assets, including cash and fixed assets[119].

Financial Performance - The total operating revenue for the reporting period was revised to CNY 4,080,206,398.29, representing a year-on-year increase of 10.72% from CNY 3,685,171,155.32[2] - The operating profit was revised to a loss of CNY 240,904,591.23, a decrease of 849.27% compared to the previous year's profit of CNY 32,151,808.82[2] - The total profit was revised to a loss of CNY 242,051,321.30, reflecting a decrease of 748.52% from the previous year's profit of CNY 37,323,486.55[2] - The net profit attributable to the parent company was revised to a loss of CNY 143,463,646.44, a decrease of 926.31% compared to the previous year's profit of CNY 28,578,460.37[2] - The basic earnings per share were revised to CNY -1.95, a decrease of 910.94% from the previous year's earnings of CNY 0.24[3] Assets and Liabilities - The total assets at the end of the reporting period were CNY 5,223,812,117.69, an increase of 4.39% from CNY 4,894,402,986.96 in the same period last year[3] - The net assets attributable to the parent company decreased by 16.80% to CNY 1,398,895,697.80 from CNY 1,567,684,666.38 in the previous year[3] Impairment Losses - The company recognized impairment losses totaling CNY 4,362 million related to the acquisition of Guangdong Guanzhen Technology Co., Ltd. due to underperformance[6] - The company also recorded impairment losses of CNY 2,175 million on fixed assets related to its leasing business[6] Future Commitments - The company expressed its commitment to improve the accuracy of future financial reporting and enhance communication with auditors[7]

广东聚石化学股份有限公司 关于中兴华会计师事务所（特殊普通合伙）履职情况 评估报告 广东聚石化学股份有限公司（以下简称"公司"）聘请中兴华会计师事务所（特 殊普通合伙）（以下简称"中兴华所"）作为公司 2024 年度财务及内部控制审计 机构。根据财政部、国资委及证监会颁布的《国有企业、上市公司选聘会计师事 务所管理办法》，公司对中兴华所 2024 年度审计过程中的履职情况进行评估。 经评估，公司认为中兴华所资质等方面合规有效，履职保持独立性，勤勉尽责， 公允表达意见，具体情况如下： 项目合伙人：黄辉，2014 年 6 月成为注册会计师。自 2013 年起从事审计工 作，2019 年开始在中兴华所执业，2022 年开始为公司提供审计服务，先后为兆 新股份（002256）、融捷股份（002192）等公司提供年度审计和专项审计服务， 具备相应专业胜任能力。近三年签署 6 家上市公司审计报告。 一、会计师事务所基本情况 （一）机构信息 中兴华会计师事务所（特殊普通合伙）成立于 1993 年，2000 年由国家工商 管理总局核准，改制为"中兴华会计师事务所有限责任公司"。2009 年吸收合 并江苏富华会计师事务所，更名 ...

证券代码：688669 证券简称：聚石化学 公告编号： 2025-022 广东聚石化学股份有限公司 关于参加 2024 年度科创板先进石化化工新材料行业 集体业绩说明会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 会议召开时间：2025 年 5 月 27 日（星期二）15:00-17:00 二、 说明会召开的时间、地点 （一） 会议召开时间：2025 年 5 月 27 日 15:00-17:00 （ 二 ） 会 议 召 开 地 点 ： 上 海 证 券 交 易 所 上 证 路 演 中 心 （ 网 址 ： https://roadshow.sseinfo.com） （三） 会议召开方式：上证路演中心网络互动 会 议 召 开 地 点 ： 上 海 证 券 交 易 所 上 证 路 演 中 心 （ 网 址 ： https://roadshow.sseinfo.com） 会议召开方式：上证路演中心网络互动 投资者可于 2025 年 5 月 22 日（星期四）至 5 月 26 日（星期一）16:00 前登录上证路演中 ...

| 关于本报告 01 | | --- | | 董事长致辞 03 | | 关于聚石化学 05 | | 附录一 年度关键绩效 111 | | 附录二 报告索引 115 | | 深化安全管理 51 | | --- | | 安全生产管理 53 | | 职业健康与安全 63 | | ESG管理体系 13 | | --- | | 利益相关方沟通 13 | | 重要性议题识别 15 | | 对标联合国可持续发展目标 | | （SDGs） 17 | | 精细品质管理 69 | | --- | | 质量管控 71 | | 客户服务管理 76 | | 供应链安全 79 | | 治理体系 21 | | --- | | 风险与合规管理 25 | | 商业道德 27 | | 研发体系 83 | | --- | | 创新成果 86 | | 知识产权保护 88 | | 应对气候变化 31 | | --- | | 循环经济 34 | | 环境合规管理 44 | | 排放控制 46 | | 资源管理 49 | | 责任雇主 93 | | --- | | 人才培养 100 | | 践行社会责任 105 | 2024 环境、社会和公司治理报告 P ...

根据《中华人民共和国公司法》《中华人民共和国证券法》《国有企业、上市 公司选聘会计师事务所管理办法》《上海证券交易所科创板上市公司自律监管指 引第 1 号——规范运作》和《广东聚石化学股份有限公司章程》《广东聚石化学 股份有限公司董事会审计委员会工作细则》等规定和要求，广东聚石化学股份有 限公司（以下简称"公司"）董事会审计委员会本着勤勉尽责的原则，切实履行 了相关职责。公司董事会审计委员会现将 2024 年度对会计师事务所履行监督职 责的情况汇报如下： 广东聚石化学股份有限公司 董事会审计委员会对中兴华会计师事务所（特殊普通 合伙）履行监督职责情况报告 二、审计委员会对会计师事务所监督情况 根据公司《审计委员会工作细则》等有关规定，公司董事会审计委员会对会 计师事务所履行监督职责的情况如下： （一）公司于 2024 年 8 月 23 日召开第六届董事会审计委员会第十次会议， 审议通过了《关于续聘会计师事务所的议案》。公司董事会审计委员会对中兴华 所的独立性、专业胜任能力、投资者保护能力进行了充分的了解和审查，在查阅 了中兴华所的基本情况、资格证照和诚信记录等相关信息后，认为其具备担任公 司财务审计机构的资质 ...